Concepta PLC (CPT) Receives Speculative Buy Rating from Beaufort Securities

Beaufort Securities reiterated their speculative buy rating on shares of Concepta PLC (LON:CPT) in a research report sent to investors on Tuesday. The firm currently has a GBX 26 ($0.32) price target on the stock.

Concepta PLC (LON:CPT) traded up 2.82% on Tuesday, reaching GBX 18.25. 227,958 shares of the company’s stock were exchanged. Concepta PLC has a 1-year low of GBX 8.25 and a 1-year high of GBX 47.94. The firm’s 50 day moving average is GBX 17.63 and its 200 day moving average is GBX 16.48.

COPYRIGHT VIOLATION WARNING: “Concepta PLC (CPT) Receives Speculative Buy Rating from Beaufort Securities” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be accessed at https://sportsperspectives.com/2017/01/11/concepta-plc-cpt-receives-speculative-buy-rating-from-beaufort-securities.html.

About Concepta PLC

Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.

Receive News & Ratings for Concepta PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply